PatriceDelafontaineMD

Cardiology • New Orleans, LA

Interventional Cardiology, Non-Invasive Cardiology

Executive Dean, Professor of Medicine, Physiology and Pharmacology, Tulane University School of Medicine

Join to view full profile

Dr. Delafontaine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Delafontaine's full profile

Already have an account?

Office
131 S Robertson street
Tulane University School of Medicine
New Orleans, LA 70112
Phone+1 504-988-5459

Education & Training

Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1984 - 1987
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1979 - 1980
Rutgers Health/Monmouth Medical CenterInternship, Internal Medicine, 1978 - 1979
University of Geneva Faculty of MedicineClass of 1977

Certifications & Licensure

NY State Medical License 1979 - Present
FL State Medical License 2021 - 2026
GA State Medical License 1989 - 2026
MA State Medical License 1985 - 2026
KS State Medical License 2001 - 2025
LA State Medical License 2003 - 2025
MO State Medical License 2015 - 2025
PA State Medical License 1979 - 1981
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Join now to see all

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Fellow (FACP) American College of Physicians, 2003
Elected Member The American Society for Clinical Investigation, 1996
Super Doctor SuperDoctors.com
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure Start of enrollment: 2013 Sep 01
Completed
Phase 1

Publications & Presentations

PubMed

EF24, a Curcumin Analog, Reverses Interleukin-18-Induced miR-30a or miR-342-Dependent TRAF3IP2 Expression, RECK Suppression, and the Proinflammatory Phenotype of Human...
Yusuke Higashi, Ryan Dashek, Patrice Delafontaine, Randy Scott Rector, Bysani Chandrasekar
Cells. 2024-10-10
7 citations
Insulin-like growth factor 1 reduces coronary atherosclerosis in pigs with familial hypercholesterolemia.
Sergiy Sukhanov, Yusuke Higashi, Tadashi Yoshida, Svitlana Danchuk, Mitzi Alfortish
JCI Insight. 2023-02-22
6 citations
Multiomics Approach Reveals an Important Role of BNIP3 in Myocardial Remodeling and the Pathogenesis of Heart Failure with Reduced Ejection Fraction.
Antoine H Chaanine, LeeAnn Higgins, Lothar Lauterboeck, Todd Markowski, Qinglin Yang
Cells. 2022-05-06

Press Mentions

Tulane Seeks 2,000 Volunteers for Johnson & Johnson Vaccine TrialsNovember 6th, 2020
Tulane University Adds Second Avenue for COVID-19 TestingApril 2nd, 2020
Delafontaine Reinstated at MU Medical SchoolFebruary 18th, 2016

Grant Support

Insulin-Like Growth Factor-1 And AtherosclerosisNational Heart, Lung, And Blood Institute2007–2012
Angiotensin II, IGF-1 And Skeletal Muscle AtrophyNational Heart, Lung, And Blood Institute2007–2011
Insulin-Like Growth Factor-1and AtherosclerosisNational Heart, Lung, And Blood Institute2004–2006
Insulin-Like Growth Factor-1 And AtherosclerosisNational Heart, Lung, And Blood Institute2003

Professional Memberships

American College of Physicians - ACP
Fellow
American College of Cardiology - ACC
Member